Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression
Status:
Terminated
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The specific aim of this study is to evaluate the efficacy and tolerability of a stimulant
(lisdexamfetamine) in the adjunctive treatment of bipolar disorder.